Cosmos Health宣布与Virax Biolabs达成分销协议

• Cosmos Health (NASDAQ:COSM) has entered into a distribution agreement with Virax Biolabs Group Limited (NASDAQ:VRAX) to distribute Virax-branded Avian Influenza Virus real-time PCR kits across various major European markets and certain Gulf Cooperation Council countries.
• Cosmos Health gains exclusive rights to distribute these kits in Greece and Cyprus, as well as non-exclusive rights in select European countries, including France, Portugal, Spain, The Netharlands, Belgium, Sweden, Finland, Denmark, Norway and Austria. 
• The agreement also grants non-exclusive distribution rights in certain Gulf Cooperation Council (GCC) countries, namely Oman and Bahrain. 
• Cosmos Health is authorized to import, sell, and distribute ViraxClear-branded kits within the agreed territories.
• Virax will oversee regulatory compliance and provide the necessary documentation to support product registration and approval in these regions.
• COSM shares fell nearly 4% on Monday.
• Source: Press release

More on Cosmos Holdings

• Seeking Alpha’s Quant Rating on Cosmos Holdings
• Historical earnings data for Cosmos Holdings
• Financial information for Cosmos Holdings